Gritstone Oncology Announces Pricing of $74.8 Million Public Offering of Common Stock Portfolio News / admin April 24, 2019 Gritstone Oncology Announces Pricing of $74.8 Million Public Offering of Common Stock Read More »
Gritstone Oncology Announces Clinical Acceleration of “Off-The-Shelf” Personalized Neoantigen Immunotherapy Program (SLATE) Following FDA Feedback Portfolio News / admin April 22, 2019 Gritstone Oncology Announces Clinical Acceleration of “Off-The-Shelf” Personalized Neoantigen Immunotherapy Program (SLATE) Following FDA Feedback Read More »
Gritstone Oncology Announces Proposed Public Offering of Common Stock Portfolio News / admin April 22, 2019 Gritstone Oncology Announces Proposed Public Offering of Common Stock Read More »
Surrozen Appoints Dr. Trudy Vanhove as Chief Medical Officer Portfolio News / admin April 11, 2019 Surrozen Appoints Dr. Trudy Vanhove as Chief Medical Officer Read More »
NGM Bio Announces Pricing of Initial Public Offering Portfolio News / admin April 3, 2019 NGM Bio Announces Pricing of Initial Public Offering Read More »
